Johnson & Johnson to Participate in the Goldman Sachs 44^th Annual Global Healthcare Conference

New Brunswick, NJ (May 10, 2023) - Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44^th Annual Global Healthcare Conference on Tuesday, June 13^th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.